MyAverix Finance
BR · Healthcare
Celyad SA (CYAD)
Biotechnology
Celyad SA (CYAD) is listed on BR in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported market cap is $12.98M, P/E ratio is 14.50, net margin is 3,952.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CYAD
Celyad SA (CYAD) — FAQ
What is Celyad SA's market cap?
Celyad SA (CYAD) has a reported market cap of $12.98M (data as of 2026-05-24).
What is CYAD's P/E ratio?
The price-to-earnings (P/E) ratio for Celyad SA (CYAD) is 14.50 (data as of 2026-05-24).
Does Celyad SA pay a dividend?
Dividend yield is not available in the current snapshot for Celyad SA (CYAD). Check the MyAverix Finance app for the latest dividend data.
What sector is Celyad SA in?
Celyad SA (CYAD) is classified in the Healthcare sector (Biotechnology industry).
What exchange is CYAD listed on?
CYAD is listed on BR.
What is Celyad SA's net margin?
Celyad SA (CYAD) reports a net margin of 3,952.4% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.